American International Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-18,521
Closed -$764K 5193
2015
Q2
$764K Sell
18,521
-1,451
-7% -$52K ﹤0.01% 1807
2015
Q1
$704K Buy
19,972
+129
+0.7% +$4.36K ﹤0.01% 1890
2014
Q4
$638K Sell
19,843
-1,199
-6% -$34.7K ﹤0.01% 1927
2014
Q3
$590K Buy
21,042
+603
+3% +$18.4K ﹤0.01% 1976
2014
Q2
$618K Sell
20,439
-413
-2% -$11.4K ﹤0.01% 1983
2014
Q1
$577K Buy
20,852
+2,245
+12% +$58.7K ﹤0.01% 1961
2013
Q4
$475K Sell
18,607
-1,307
-7% -$40.3K ﹤0.01% 2068
2013
Q3
$595K Sell
19,914
-966
-5% -$26.9K ﹤0.01% 1823
2013
Q2
$600K Buy
+20,880
New +$575K ﹤0.01% 1721

Other funds holding BRLI

American International Group's BRLI Position: Q3 2015 in Review

American International Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 18,521 shares — an estimated $764K sold.

American International Group first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $764K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • American International Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • American International Group sold 18,521 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $764K.
  • American International Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • American International Group's BIO-REFERENCE LABS INC-NEW- position peaked at $764K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on American International Group's 13F filing for Q3 2015, filed 12 Nov 2015.